Pharmaceutical active substance for the treatment of hepatitis A, hepatitis C, borrelia and/or multiple sclerosis, comprises an unpurified gland secretion obtained from animals of the class Diplopoda

摘要

A pharmaceutical active substance (I) for the treatment of hepatitis A, hepatitis C, borrelia and/or multiple sclerosis, comprises at least an unpurified gland secretion obtained from animals of the class Diplopoda. An independent claim is included for a procedure for preparing the active substance comprising: (a) dissolving gland secretion of an African Diplopoda in sodium chloride with 10% peptide toxin and an antagonistically or synergistically active-/penetration-substance to saturate; (b) heating the obtained solution at 50 [deg]C over for at least 3 days in a sterile deduction; and (c) filling up the solution with sodium chloride with 10% of peptide toxin and the antagonistically or synergistically active-/penetration substance. ACTIVITY : Antiinflammatory; Hepatotropic; Virucide; Neuroprotective; Antibacterial. No biological data given. MECHANISM OF ACTION : None given.